Cdt Equity(NASDAQ) CDTTW

Market CapN/A

Since IPO (2022)-94%

5 YearN/A

1 Year-28%

1 Month-4%

$0.01

+0.00%

+0.00Today

Cdt Equity last closing stock price
Metric	Price	Date
Last close	USD 0.01	2026-08-31

Cdt Equity stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+9.09%	USD 0.01	2026-08-21
1 month	-4.43%	USD 0.01	2026-07-31
3 month	+25.58%	USD 0.01	2026-06-02
Year to date	+96.36%	USD 0.01	2025-12-31
1 year	-28%	USD 0.02	2025-08-27
3 year	-84.57%	USD 0.07	2023-09-01
Since inception	-93.65%	USD 0.17	2022-03-31

Cdt Equity Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$1.45B

Net Income (TTM)

$91.12M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.01

Volume

200

Open

$0.01

Price

$0.01

Volume

200

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $0.02

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.01

Volume

200

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $0.02

Estimated Earnings Date

N/A

CDTTW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cdt Equity

CDT Equity Inc. is a biotechnology company focused on advancing the development and market introduction of clinical assets. Established in October 2021, the company operates from Naples, Florida, and aims to innovate within the healthcare sector.

Products and Services

Development of clinical assets in biotechnology
Research and development in healthcare solutions
Market introduction of innovative medical technologies

Growth Outlook

Recent quarterly revenue reached $750 million, indicating strong market demand
Net income for Q2 was $68.5 million, showcasing profitability
Operating income margin improved to 15.6%, reflecting operational efficiency

Financial Highlights

Trailing twelve months (TTM) revenue of $1.45 billion demonstrates robust growth
Current ratio of 2.14 indicates strong liquidity position
Net profit margin of 6.3% highlights effective cost management

CDT Equity Inc. has shown significant growth potential in the biotechnology sector, with recent financial results indicating a strong upward trajectory. The company’s focus on innovative clinical assets positions it well within a rapidly evolving healthcare landscape. The impressive revenue figures and profitability metrics suggest that CDT Equity Inc. is effectively navigating market challenges while capitalizing on opportunities for expansion. Investors may find the company's strategic direction and financial performance compelling as it continues to advance its mission in the biotechnology field.

AI Generated • Aug 14, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Headquarters

Naples, FL 34103, US

CDTTW Financials

Key Financial Metrics (TTM)

Gross Margin

38.65%

Operating Margin

11.55%

Net Income Margin

6.30%

Return on Equity

9.26%

Return on Capital

-1.44%

Return on Assets

2.60%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

6.47%

Stock Overview

Market Cap

N/A

Shares Outstanding

Volume

200

Avg. Volume

23.07K

Financials (TTM)

Gross Profit

$559.12M

Operating Income

$167.14M

EBITDA

$243.28M

Operating Cash Flow

$124.45M

Capital Expenditure

-$125.74M

Free Cash Flow

-$1.29M

Cash & ST Invst.

$348.66M

Total Debt

$1.32B

Cdt Equity Performance Analysis

Cdt Equity sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-28	N/A
Q4	2025-12-31	N/A
Q1	2026-03-29	N/A
Q2	2026-06-28	7.7%

Cdt Equity sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-28	69.9%
Q4	2025-12-31	29.7%
Q1	2026-03-29	661.8%
Q2	2026-06-28	-98.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$750.16M

N/A

Gross Profit

$301.03M

N/A

Gross Margin

40.13%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$68.54M

+1237.0%

EBITDA

$159.66M

+3204.3%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

$348.66M

+10363.8%

Total Debt

$1.32B

+63754.2%

Accounts Receivable

$534.16M

+217924.1%

Inventory

$420.59M

N/A

Long Term Debt

$1.32B

+2867787.0%

Short Term Debt

$0.00

-100.0%

Return on Assets

2.60%

N/A

Return on Invested Capital

5.86%

N/A

Free Cash Flow

$2.08M

+180.6%

Operating Cash Flow

$42.74M

+1756.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

DRMADermata Therapeutics, Inc.

DRMADermata Therapeutics, Inc.$1.29-3.73%

AKTXAkari Therapeutics, Plc

AKTXAkari Therapeutics, Plc$10.43-2.52%

XAGELongevity Health Holdings Inc.

XAGELongevity Health Holdings Inc.$0.22+0.00%

PPBTPurple Biotech Ltd.

PPBTPurple Biotech Ltd.$1.70+1.19%

REVBRevelation Biosciences, Inc.

REVBRevelation Biosciences, Inc.$1.00-4.76%

SLXNWSilexion Therapeutics Ltd.

SLXNWSilexion Therapeutics Ltd.$0.01-9.29%

PBMPsyence Biomedical Ltd.

PBMPsyence Biomedical Ltd.$4.34+3.09%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About CDTTW

What is the current price of Cdt Equity?

Cdt Equity is trading at $0.01 per share.

What is the 52-week range for Cdt Equity?

Over the past 52 weeks, Cdt Equity has traded between $0.01 and $0.02.

How much debt does Cdt Equity have?

Cdt Equity total debt is unavailable.

How much cash does Cdt Equity have on hand?

Cdt Equity does not have cash on hand data available.

What is Cdt Equity’s dividend yield?

Cdt Equity does not currently have a dividend yield.

Cdt Equity(NASDAQ) CDTTW

Cdt Equity Financials at a Glance

CDTTW News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cdt Equity

CDTTW Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cdt Equity Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CDTTW

What is the current price of Cdt Equity?

What is the 52-week range for Cdt Equity?

How much debt does Cdt Equity have?

How much cash does Cdt Equity have on hand?

What is Cdt Equity’s dividend yield?

Premium Investing Services